Open Access iconOpen Access

ARTICLE

Role of J stent as a minimally invasive treatment option for ureteropelvic junction obstruction

Murat Yavuz Koparal1, Burak Elmas2,*, Serhat Gurocak1, Cihat Aytekin1, Mustafa Ozgur Tan1

1 Department of Urology, School of Medicine, Gazi University, Ankara, 06560, Turkey
2 Urology Clinic, Kizilcahamam State Hospital, Ankara, 06890, Turkey

* Corresponding Author: Burak Elmas. Email: email

Canadian Journal of Urology 2025, 32(3), 199-207. https://doi.org/10.32604/cju.2025.063616

Abstract

Aim: The aim of this study was to investigate the factors affecting treatment success in children that got either pyeloplasty or J stent placement in ureteropelvic junction obstruction (UPJO). Patients and Methods: The study comprised 126 patients who either J stent placement or pyeloplasty performed by the same physician for UPJO from 2012 to 2022. The criteria for surgical intervention adhered to the European Association of Urology (EAU) recommendations. Symptomatic patients with verified obstruction, with a split renal function (SRF) over 40%, low-grade hydronephrosis (Society of Fetal Urology grade 2), and an obstructive segment measuring less than 1 cm, had Double-J stent placement. Furthermore, in infants exhibiting poor health or development retardation, a J stent was inserted as a temporary measure to alleviate obstruction and maintain renal function, notwithstanding the recommendation for pyeloplasty. Results: The treatment success rate was 43.9% in the J stent group and 88.4% in the pyeloplasty group, with a statistically significant difference (p < 0.001). The kind of procedure (pyeloplasty vs. stent) was the sole independent prognostic factor predicting treatment success (HR: 4.77, p < 0.001) in the multiple logistic regression analysis. No statistically significant change was observed in preoperative and postoperative SRF (48% vs. 48.5%, p = 0.923) among patients with stent failure, confirming a transient preservation of functional advantage. Conclusion: The placement of a stent may have restricted success rates in specific patients with UPJO. Preserving renal function may be advantageous until definitive surgery, particularly in cases where there are hazards associated with anesthesia and invasive procedures.

Keywords

hydronephrosis; ureteropelvic junction obstruction; treatment

Cite This Article

APA Style
Koparal, M.Y., Elmas, B., Gurocak, S., Aytekin, C., Tan, M.O. (2025). Role of J stent as a minimally invasive treatment option for ureteropelvic junction obstruction. Canadian Journal of Urology, 32(3), 199–207. https://doi.org/10.32604/cju.2025.063616
Vancouver Style
Koparal MY, Elmas B, Gurocak S, Aytekin C, Tan MO. Role of J stent as a minimally invasive treatment option for ureteropelvic junction obstruction. Can J Urology. 2025;32(3):199–207. https://doi.org/10.32604/cju.2025.063616
IEEE Style
M. Y. Koparal, B. Elmas, S. Gurocak, C. Aytekin, and M. O. Tan, “Role of J stent as a minimally invasive treatment option for ureteropelvic junction obstruction,” Can. J. Urology, vol. 32, no. 3, pp. 199–207, 2025. https://doi.org/10.32604/cju.2025.063616



cc Copyright © 2025 The Author(s). Published by Tech Science Press.
This work is licensed under a Creative Commons Attribution 4.0 International License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
  • 295

    View

  • 108

    Download

  • 0

    Like

Share Link